Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Biomaterials. 2016 May 3;98:53–63. doi: 10.1016/j.biomaterials.2016.04.040

Figure 6.

Figure 6

Ĉerenkov imaging of Dg-cSCK:pDNA nanocomplex clearance. Mice were positioned in the supine position for luminescent imaging of ventral surface after intratracheal administration of 131I-labeled Dg-cSCK:pDNA nanocomplexes (A) immediately post administration, (B) after 3 days and (C) 7 days. The intensity scale is represented on the right.